Stock Fundamentals

Company Information

Company Name
Aura Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US05153U1079
CIK: 0001501796
CUSIP: 05153U107
Currency: USD
Full Time Employees: 113
Phone: 617 500 8864
Fiscal Year End: December
IPO Date: Oct 29, 2021
Description:

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Address:

80 Guest Street, Boston, MA, United States, 02135

Directors & Officers

Name Title Year Born
Mr. Anthony S. Gibney Chief Financial & Business Officer 1971
Dr. Jill J. Hopkins M.D. Chief Medical Officer & President of Research and Development 1965
Ms. Natalie C. Holles President, CEO & Director 1973
Ms. Amy Elazzouzi Interim Principal Accounting Officer, Senior VP of Finance & Treasurer 1974
Dr. Mark Plavsic D.V.M., Ph.D. Chief Technology Officer 1961
Mr. Conor Kilroy Chief Legal Officer & Secretary 1982
Mr. Patrick Nealon Senior Vice President of Clinical Development Operations NA
Dr. Anthony Daniels M.D. VP & Therapeutic Area of Head Ocular Oncology NA
Mr. Joe McQuaid M.D. VP & Therapeutic Area Head of Urologic Oncology NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 16, 2026 Conor Kilroy N/A Sale 11.74K $7.02 $82.40K
Feb 17, 2026 Amy Elazzouzi N/A Sale 8.55K $5.06 $43.26K
Feb 17, 2026 Conor Kilroy N/A Sale 12.08K $5.05 $61.00K
Feb 17, 2026 Janet Jill Hopkins N/A Sale 20.40K $5.06 $103.23K
Feb 17, 2026 Los Pinos Elisabet De N/A Sale 47.65K $5.06 $241.10K
Feb 17, 2026 Mark Plavsic N/A Sale 15.89K $5.05 $80.24K
Jan 20, 2026 Amy Elazzouzi N/A Sale 1.58K $4.86 $7.68K
Jan 20, 2026 Los Pinos Elisabet De N/A Sale 16.93K $4.86 $82.27K
Nov 17, 2025 Janet Jill Hopkins N/A Sale 17.11K $5.42 $92.73K
Oct 29, 2025 Amy Elazzouzi N/A Sale 896.00 $6.35 $5.69K
Oct 29, 2025 Los Pinos Elisabet De N/A Sale 9.05K $6.35 $57.46K
Oct 16, 2025 Mark Plavsic N/A Sale 12.17K $6.35 $77.27K
Aug 18, 2025 Amy Elazzouzi N/A Sale 7.72K $6.70 $51.74K
May 16, 2025 Anthony S Gibney N/A Purchase 50.00K $4.90 $245.00K
May 16, 2025 Anthony S Gibney N/A Sale 1.52K $5.15 $7.82K
May 16, 2025 David Michael Johnson N/A Purchase 20.00K $4.90 $98.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Matrix Capital Management Company, LLC 6.92M Mar 31, 2026 6.70% $100.00 0.00%
Frazier Life Sciences Management, L.P. 5.10M Mar 31, 2026 4.93% $0.88 0.00%
Adage Capital Partners Gp LLC 4.88M Mar 31, 2026 4.72% $0.05 0.00%
Long Focus Capital Management, LLC 4.62M Mar 31, 2026 4.47% $0.81 0.00%
Suvretta Capital Management, LLC 4.37M Mar 31, 2026 4.23% $0.75 0.00%
BlackRock Inc 3.59M Mar 31, 2026 3.47% $0.00 0.74%
Medicxi Ventures Management (Jersey) Ltd 3.04M Mar 31, 2026 2.94% $2.07 0.00%
Vanguard Group Inc 2.94M Dec 31, 2025 2.84% $0.00 1.59%
Vanguard Capital Management, LLC 2.24M Mar 31, 2026 2.17% $0.00 0.00%
Nantahala Capital Management, LLC 2.12M Mar 31, 2026 2.05% $0.52 0.00%
Franklin Resources Inc 2.07M Mar 31, 2026 2.00% $0.00 -5.72%
Geode Capital Management, LLC 1.31M Mar 31, 2026 1.27% $0.00 4.41%
Millennium Management LLC 1.10M Mar 31, 2026 1.06% $0.00 77.80%
State Street Corp 964.67K Mar 31, 2026 0.93% $0.00 4.12%
Easterly Investment Partners. 941.40K Mar 31, 2026 0.91% $0.48 0.00%
B Group, Inc 597.58K Mar 31, 2026 0.58% $2.96 4.37%
Dimensional Fund Advisors, Inc. 558.16K Mar 31, 2026 0.54% $0.00 7.77%
Balyasny Asset Management LLC 557.65K Mar 31, 2026 0.54% $0.00 0.00%
Regency Capital Management Inc.\DE 532.50K Mar 31, 2026 0.52% $1.59 -1.13%
Northern Trust Corp 430.52K Mar 31, 2026 0.42% $0.00 4.29%

Shares Statistics

Shares Outstanding: 103.39M
Shares Float: 93.38M
% Insiders: 101.10%
% Institutions: 5,102.70%
Short % Float: 4.37%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.55M 1.50% ▲ 0.00% Apr 30, 2026
2 Franklin Biotechnology Discv A(acc)USD 1.31M 1.26% ▲ 0.00% Apr 30, 2026
3 iShares Russell 2000 ETF 1.05M 1.01% ▲ 0.93% May 29, 2026
4 Franklin Biotechnology Discovery A 765.62K 0.74% ▲ 0.00% Apr 30, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 640.71K 0.62% ▲ 0.90% Apr 30, 2026
6 Fidelity Small Cap Index 439.47K 0.43% ▲ 2.34% Mar 31, 2026
7 iShares Biotechnology ETF 406.81K 0.39% ▲ 25.53% May 29, 2026
8 Fidelity Extended Market Index 310.98K 0.30% ▼ 0.36% Apr 30, 2026
9 iShares Russell 2000 Value ETF 269.44K 0.26% ▲ 0.00% May 29, 2026
10 Russell 2000 Equity Index Fund B 254.35K 0.25% ▼ 0.05% Dec 31, 2025

Valuation Metrics

Enterprise Value: $564.97M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $662.71M
EBITDA: $-117.51M
Book Value: $1.67
Earnings/Share: $-1.71
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -50.59%
ROE (TTM): -95.57%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.15x 0.02x 0.19x N/A -0.03x
2024-12-31 10.77x 0.02x 0.17x N/A -0.04x
2023-12-31 18.76x 0.01x 0.11x N/A -0.04x
2022-12-31 18.81x 0.02x 0.13x -70.94x -0.05x
2021-12-31 20.90x 0.00x 0.05x -2,711.54x -0.02x
2020-12-31 6.94x 0.00x 0.12x -7,402.00x 0.00x
2019-12-31 5.42x 0.00x 0.17x -4,828.00x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AURA.US!